Fig. 4

CD34-selected cells were incubated for several hours with daratumumab, BRIC229 or both and then plated in progenitor cell assays to assess their function. Pre-incubation did not diminish colony production compared to controls (mean ± SD)
CD34-selected cells were incubated for several hours with daratumumab, BRIC229 or both and then plated in progenitor cell assays to assess their function. Pre-incubation did not diminish colony production compared to controls (mean ± SD)